The addition of a TNF‐α‐neutralizing antibody restored both adiponectin expression levels and BMAd number; however, interestingly, viability was not altered by blockade of TNF‐α, suggesting additional mechanisms may contribute to the effect of BMAds on myeloma cell viability. Here, ADIPOQ is linked to plasma cell myeloma.